Ergoteles’s CareDx CDNA Stock Holding History

Ergoteles’s Portfolio CDNA Stock Details CDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,202	Closed	-$86.7K	–	175
2023 Q2	$86.7K	Buy	+10,202	New	+$85.1K	﹤0.01%	924
2022 Q2	–	Sell	-29,240	Closed	-$1.08M	–	1670
2022 Q1	$1.08M	Buy	+29,240	New	+$1.14M	0.04%	409
2021 Q3	–	Sell	-5,900	Closed	-$540K	–	1258
2021 Q2	$540K	Buy	+5,900	New	+$469K	0.01%	772

Other funds holding CDNA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Ergoteles's CDNA Position: Q3 2023 in Review

Ergoteles sold out of CareDx (CDNA) in Q3 2023, closing a stake of 10,202 shares — an estimated $86.7K sold.

Ergoteles first reported a position in CDNA in Q2 2021 and held it in 3 quarters. The position peaked at $1.08M in Q1 2022. 150 funds tracked by Wall St. Rank hold CDNA as of Q3 2023.

Ergoteles reported no remaining CareDx position as of Q3 2023 after selling out during the quarter.
Ergoteles sold 10,202 CareDx shares in Q3 2023, an estimated $86.7K.
Ergoteles first reported a position in CareDx in Q2 2021 and held it in 3 quarters.
Ergoteles's CareDx position peaked at $1.08M in Q1 2022.
150 funds tracked by Wall St. Rank held CareDx as of Q3 2023.

Based on Ergoteles's 13F filing for Q3 2023, filed 14 Nov 2023.